Revaia
VC Fund
Paris, France
Revaia is a growth equity investment fund that focuses on European technology companies with a sustainable ethos. It uses its heart, soul, and sweat to help them navigate the entire life cycle from the growth stage to IPO and beyond. Since the launch of its fund in 2019, which is now closing, Revaia has hired 15 staff and established a presencein Toronto and New York. It also opened an office in Berlin earlier this year.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 41%
Last updated:
For AI agents: llms.txt
Industries Revaia invests in
Stages Revaia invests in
Countries Revaia invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alice Albizzati
|
|||
Elina Berrebi
|
|||
Anne-Pascale Niez
|
|||
|
Bettina Denis
|
|||
Jérémie Falzone
|
|||
| See all 7 contacts → | |||
Investment Focus
Industry
- Software 5 (14%)
- SaaS 4 (11%)
- Apps 2 (5%)
- Mobile 2 (5%)
- FinTech 2 (5%)
Stage
- Series C 4 (11%)
- Series B 3 (8%)
- Series D 3 (8%)
- Series A 1 (3%)
- Funding Round 1 (3%)
Country
- France 8 (22%)
- United Kingdom 2 (5%)
- Switzerland 1 (3%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alice Albizzati
Fouding Partner
|
Fouding Partner | Total investments: 5 | Find email | |
|
Elina Berrebi
Fouding Partner
|
Fouding Partner | Total investments: 4 | Find email | |
|
Anne-Pascale Niez
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
|
Bettina Denis
CFO / COO
|
CFO / COO | Total investments: 0 | Find email | |
|
Jérémie Falzone
Partner
|
Partner | Total investments: 2 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Semble
|
Semble is a healthcare technology company that develops practice management and electronic health record software for private healthcare providers. The company offers an integrated platform that combines patient records, appointment scheduling, telehealth, billing, payments, clinical documentation, prescribing, and care coordination tools within asingle system. Its software is designed to support the delivery and administration of healthcare services across clinics, medical practices, and multi-site healthcare organizations. The platform enables healthcare professionals to manage patient journeys from initial booking through consultation, treatment, follow-up care, and payment processing. It includes electronic health record functionality, clinical note management, patient communication tools, online booking capabilities, and workflow automation features that help streamline administrative and clinical processes.In addition to clinical and administrative functions, the company offers analytics, reporting, patient engagement, and automation tools that help healthcare organizations manage operations and monitor performance. Its solutions are used by a range of healthcare providers, including physicians, specialists, mental health professionals, physiotherapists, pharmacies, and occupational health organizations. | $40.3M / Series C / Jun 04, 2026 | |
Synera
|
Bremen-based software company ELISE GmbH has created the first low-code development platform for engineering. Engineers can use it to automate recurring tasks across all domains in a single environment. Thus, unlike in classical design processes, ELISE enables algorithm-based modeling. As a result of this automation, developers can return tocreative activities and ultimately design faster and better products. On ELISE, all data and the entire expert knowledge of the development process are integrated. Engineers are thus provided with technical capabilities that are otherwise only available to software developers, despite their diverse skills. This is achieved through a visual programming language for which no special IT knowledge is required. Users of ELISE work in numerous industries, including automotive, aerospace and medical technology. The platform’s potential has been proven at customers such as Volkswagen, BMW, Hyundai, Brose and EDAG. With the help of ELISE, they were able to design individual components up to 90 percent faster than before. | $40M / Series B / Apr 14, 2026 | |
Hublo
|
Hublo builds a simple and user-friendly digital platform to help hospitals, clinics and retirement homes find staff easily and efficiently, so that they can refocus on their core mission: saving lives. | $47.3M / Venture - Series Unknown / Feb 03, 2026 | |
|
Hublo
|
Hublo builds a simple and user-friendly digital platform to help hospitals, clinics and retirement homes find staff easily and efficiently, so that they can refocus on their core mission: saving lives. | $47.3M / Venture - Series Unknown / Feb 03, 2026 | |
Intersec
|
Intersec is a leading Fast Data software vendor, designing innovative platforms enabling companies to leverage their Data. Their disruptive technology crunches and consolidates huge amounts of data coming from heterogeneous network equipment and IT, and turns them into actionable insights in real-time. Applications range from Contextual Marketing,Geolocation Intelligence, Smart Cities, IoT and Business Analytics. Awarded Most Innovative LBS Solution and Best Cloud Analytics Solution in 2017, Intersec has live solutions running all over the globe. | Private Equity / Dec 16, 2025 | |
|
Hublo
|
Hublo builds a simple and user-friendly digital platform to help hospitals, clinics and retirement homes find staff easily and efficiently, so that they can refocus on their core mission: saving lives. | $23.2M / Oct 23, 2025 | |
|
Hublo
|
Hublo builds a simple and user-friendly digital platform to help hospitals, clinics and retirement homes find staff easily and efficiently, so that they can refocus on their core mission: saving lives. | $23.2M / Oct 23, 2025 | |
Coralogix
|
Coralogix is a full-stack observability platform that enables businesses to monitor and manage data in real time, providing instant insights without the need for indexing. The platform supports Log Analytics, application performance monitoring (APM), security information and event management (SIEM), real user monitoring (RUM), and infrastructuremonitoring, offering complete visibility into AI performance, security, and governance in a single solution. Coralogix offers a simple pricing model based on data volume, along with world-class support that ensures rapid response times and swift resolutions. | $115M / Series E / Jun 17, 2025 | |
Definely
|
Definely offers a suite of AI-powered LegalTech tools designed to assist legal teams during contract drafting and review processes. The Definely Suite integrates directly into Microsoft Word and includes Vault for accessing precedent clauses and definitions, Draft for editing in-context across documents, Enhance for AI-assisted drafting and review,Proof for automated legal proofreading, and PDF for scanning critical terms and references in PDF contracts. Each tool operates within existing workflows to surface key information, flag inconsistencies, and maintain document context without requiring navigation away from clauses. Definitely’s multi-agent AI system, Enhance, applies specialized agents to tasks such as summarization and clause suggestion, aiming to automate detailed legal operations. This technology supports legal teams by reducing manual searching and helping ensure accuracy during contract preparation. | $30M / Series B / Jun 09, 2025 | |
Sekoia
|
SEKOIA is the SaaS cybersecurity that analyzes and understands emerging threats. It specialties in cybersecurity, consulting, innovation, RedTeam, BlueTeam, cert, threatintel, sekoia.io, and siem as a service. | $28.5M / Series B / Apr 09, 2025 | |
| See all 37 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Revaia invest in?
Revaia invests primarily in Software, SaaS and Apps startups, most often at Series C and Series B stage. Most of the 37 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Revaia?
Public channels for Revaia include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Revaia?
The team at Revaia includes Alice Albizzati (Fouding Partner), Elina Berrebi (Fouding Partner) and Anne-Pascale Niez (Operating Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
